Tongue Cancer Active Not Recruiting Phase 2 / 3 Trials for Mitometh (DB12117)

IndicationStatusPhase
DBCOND0029843 (Tongue Cancer)Active Not Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01810913Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck CancerTreatment